Inhaled anticholinergics: increased risk of major adverse CV events?
- 7 Downloads
KeywordsChronic Obstructive Pulmonary Disease Tiotropium Ipratropium Ipratropium Bromide Nonfatal Stroke
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Singh S, Loke YK, Furberg CD.Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA: the Journal of the American Medical Association 300: 1439-1450, No. 12, 24 Sep 2008Google Scholar
- 2.Boehringer Ingelheim.Established Safety Profile of SPIRIVA(R) Confirmed by 30 Rigorously Controlled Clinical Trials. Media Release: 23 Sep 2008. Available from: URL: http://www.boehringer-ingelheim.com
© Adis International limited or Adis Data Information BV 2008